The effect of the medicinal mushrooms agaricus brasiliensis and ganoderma lucidum (Higher basidiomycetes) on the erythron system in normal and streptozotocin-induced diabetic rats

International Journal of Medicinal Mushrooms

Volumn 17, Issue 3, 2015, Pages 277-286

  Vitak, Taras Y ^a   Wasser, Solomon P ^a   Nevo, Eviatar ^a   Sybirna, Natalia O ^b  

^a UNIVERSITY OF HAIFA   (Israel)

^b IVAN FRANKO NATIONAL UNIVERSITY OF LVIV   (Ukraine)

Author keywords

Agaricus brasiliensis; Diabetes mellitus; Erythron system; Ganoderma lucidum; Medicinal mushrooms; Red blood cell; Streptozotocin

Indexed keywords

AGARICUS BRASILIENSIS EXTRACT; FUNGAL EXTRACT; GANODERMA LUCIDUM EXTRACT; HEMOGLOBIN A1C; HEMOGLOBIN F; PLACEBO; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; PLANT MEDICINAL PRODUCT; POWDER; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE; ERYTHROCYTE COUNT; ERYTHROPOIESIS; FUNGAL BIOMASS; GLUCOSE BLOOD LEVEL; HEMOLYSIS; MALE; MOUSE; MYCELIUM; NONHUMAN; RETICULOCYTE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SUBMERGED CELL CULTURE; ADMINISTRATION AND DOSAGE; AGARICUS; ANIMAL; BLOOD; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; GANODERMA LUCIDUM; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; POWDER; RAT; WISTAR RAT;

AGARICUS BRASILIENSIS; ANIMALIA; BASIDIOMYCOTA; GANODERMA LUCIDUM; RATTUS;

AGARICUS; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; ERYTHROCYTES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MYCELIUM; PLANT PREPARATIONS; POWDERS; RATS; RATS, WISTAR; REISHI; STREPTOZOCIN;

EID: 84932102405     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushrooms.v17.i3.70     Document Type: Article

References (32)

1. Lebastchi J, Herold KC. Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetes. Cold Spring Harb Perspect Med. 2012;2(6):a007708.
2. Buys AV, Rooy M-J, Soma P, Papendorf D, Lipinski B, Pretoriu E. Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study. Cardiovasc Diabetol. 2013;12:25.
3. Bondar TP, Kozinets GI. Morphofunctional condition of the peripheral blood erythrocytes in late vascular compli­cations of diabetes mellitus of type 2 (literature review) [article in Russian]. Klin Lab Diagn. 2002;(12):22–24, 33–34.
4. Bodnar TP, Shmarov DA, Kozinets GI. Morphometric and biochemical analysis of erythrocytes in smoking patients with late vascular complications of diabetes mellitus [article in Russian]. Klin Lab Diagn. 2003;8:37–40.
5. Starodubtseva MN, Kuznetsova TG, Yegorenkov NI, Cherenkevich SN. Structural and mechanical characteristics of erythrocyte membranes in patients with type 2 diabetes mellitus. Bull Exp Biol Med. 2008;145(1):99–103.
6. Desouky OS. Rheological and electrical behavior of erythrocytes in patients with diabetes mellitus. Romanian J Biophys. 2009;19(4):239–50.
7. Liday C. Overview of the guidelines and evidence for the pharmacologic management of type 2 diabetes mellitus. Pharmacotherapy. 2011;31(12):37–43.
8. Seino S, Takahashi H, Takahashi T, Shibasaki T. Treating diabetes today: a matter of selectivity of sulphonylureas. Diabetes Obes Metab. 2012;14:9–13.
9. Lo HC, Wasser SP. Medicinal mushrooms for glycemic control in diabetes mellitus: history, current status, future perspectives, and unsolved problems (review). Int J Med Mushrooms. 2011;13(5):401–26.
10. Wasser SP. Medicinal mushroom science: history, current status, future trends, and unsolved problems. Int J Med Mushrooms. 2010;12(1):1–16.
11. Firenzuoli F, Gori L, Lombardo G. The medicinal mushroom Agaricus blazei Murrill: review of literature and pharmaco-toxicological problems. Evid Based Complement Alternat Med. 2008;5(1):3–15.
12. Oh TW, Kim YA, Jang WJ, Byeon JI, Ryu CH, Kim JO, Ha YL. Semipurified fractions from the submerged-culture broth of Agaricus blazei Murrill reduce blood glucose levels in streptozotocin-induced diabetic rats. J Agric Food Chem. 2010;58:4113–19.
13. Di Naso FC, De Mello RN, Bona S, Dias AS, Porawski M, Ferraz AB, Richter MF, Marroni NP. Effect of Agaricus blazei Murrill on the pulmonary tissue of animals with streptozotocin-induced diabetes. Exp Diabetes Res. 2010;2010:543926.
14. Niwa A, Tajiri T, Higashino H. Ipomoea batatas and Agaricus blazei ameliorate diabetic disorders with therapeutic antioxidant potential in streptozotocin-induced diabetic rats. J Clin Biochem Nutr. 2011;48:194–202.
15. De Silva DD, Rapior S, Hyde KD, Bahkali AH. Medicinal mushrooms in prevention and control of diabetes mellitus. Fungal Divers. 2012;56:1–29.
16. Zhang HN, He JH, Yuan L, Lin ZB. In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage. Life Sci. 2003;73(18):2307–19.
17. Jia J, Zhang X, Hu YS, Wu Y, Wang QZ, Li NN, Guo QC, Dong XC. Evaluation of in vivo antioxidant activities of Ganoderma lucidum polysaccharides in STZ-diabetic rats. Food Chem. 2009;115(1):32–36.
18. Seto SW, Lam TY, Tam HL, Au AL, Chan SW, Wu JH, Yu PH, Leung GP, Ngai SM, Yeung JH, Leung PS, Lee SM, Kwan YW. Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice. Phytomedicine. 2009;16(5):426–36.
19. Meng G, Zhu H, Yang S, Wu F, Zheng H, Chen E, Xu J. Attenuating effects of Ganoderma lucidum polysac­charides on myocardial collagen cross-linking relates to advanced glycation end product and antioxidant enzymes in high-fat-diet and streptozotocin-induced diabetic rats. Carbohydr Polym. 2011;84(1):180–85.
20. Cohen N, Cohen J, Asatiani MD, Varshney VK, Yu HT, Yang YC, Li YH, Mau JL, Wasser SP. Chemical compo­sition and nutritional and medicinal value of fruit bodies and submerged cultured mycelia of culinary-medicinal higher Basidiomycetes mushrooms. Int J Med Mush­rooms. 2014;16(3):273–91.
21. Sybirna NO, Burda VA, Chaika YP. Methods of research of blood system [article in Ukranian]. Lviv: Publication Center of Lviv National University; 2006.
22. Gitelzon II, Terskow IA. Erythrograms as the method for clinical blood examination [article in Russian]. Krasnoyarsk: Siberian Branch, the USSR Academy of Science; 1954.
23. Lyons TJ, Basu A. Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. Transl Res. 2012;159(4):303–12.
24. Moussa SAA. Biophysical changes in red blood cells and hemoglobin components of diabetic patients. J Genet Eng Biotechnol. 2007;5(1):27–32.
25. Oyedemi SO, Adewusi EA, Aiyegoro OA, Akinpelu DA. Antidiabetic and haematological effect of aqueous extract of stem bark of Afzelia africana (Smith) on strep­tozotocin-induced diabetic Wistar rats. Asian Pac J Trop Biomed. 2011;1(5):353–58.
26. Saliu JA, Elekofehinti OO, Komolafe K, Oboh G. Ef­fects of some green leafy vegetables on the haematologi­cal parameters of diabetic rats. J Nat Prod Plant Resour. 2012;2(4):482–85.
27. Nahideh T, Gholamreza D, Mohammad AHF, Heidar AE. Variation in body weight and some hematological param­eters in streptozotocin-induced diabetic rats, treated with Teucrium orientale. Pharmacol Online. 2013;3:32–36.
28. Krejpcio Z, Wójciak RW. The selected iron management parameters in STZ-induced diabetic rats. Trace Elements Electrolytes. 2010;27(3):115–18.
29. Ferents IV, Brodyak IV, Lyuta MY, Kulachkovsky OR, Sybirna NO. Effects of agmatine treatment on morpho­functional characteristics of the erythron in experimental diabetes mellitus in rats [article in Ukranian]. Fiziol Zh. 2014;60(4):70–79.
30. Burda V, Byront N, Sybirna N, Kleveta G. Investiga­tion of erythrone functional state under the condition of streptozotocin-induced diabetes [article in Ukranian]. Visnyk Lvivskoho Universytetu Seriia Biolohichna. 2002;28:21–27.
31. Lee MH, Kim JH, Im MW, Choi JW. Associations between enhanced fetal hemoglobin levels and ineffective reticulocyte production in diabetics. Acta Heamatol. 2009;122(4):247–51.
32. Choi JW, Nahm CH, Lee MH. Relationships of fetal-type erythropoiesis versus nitric oxide production and gly­cated hemoglobin levels in diabetics. Ann Clin Lab Sci. 2011;41(3):224–28.